| Year |
Citation |
Score |
| 2023 |
Frias-Gomez J, Alemany L, Benavente Y, Clarke MA, de Francisco J, De Vivo I, Du M, Goodman MT, Lacey J, Liao LM, Lipworth L, Lu L, Merritt MA, Michels KA, O'Connell K, ... ... Yu H, et al. Night shift work, sleep duration and endometrial cancer risk: A pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2). Sleep Medicine Reviews. 72: 101848. PMID 37716022 DOI: 10.1016/j.smrv.2023.101848 |
0.31 |
|
| 2023 |
Wang S, Xie L, Zhuang J, Qian Y, Zhang G, Quan X, Li L, Yu H, Zhang W, Zhao W, Qian B. Association between use of antihypertensive drugs and the risk of cancer: a population-based cohort study in Shanghai. Bmc Cancer. 23: 425. PMID 37165412 DOI: 10.1186/s12885-023-10849-8 |
0.313 |
|
| 2023 |
Murakami K, Furuya H, Hokutan K, Goodison S, Pagano I, Chen R, Shen CH, Chan MWY, Ng CF, Kobayashi T, Ogawa O, Miyake M, Thornquist M, Shimizu Y, Hayashi K, ... ... Yu H, et al. Association of SNPs in the PAI1 Gene with Disease Recurrence and Clinical Outcome in Bladder Cancer. International Journal of Molecular Sciences. 24. PMID 36902377 DOI: 10.3390/ijms24054943 |
0.422 |
|
| 2023 |
Shi J, Kraft P, Rosner B, Benavente Y, Black A, Brinton LA, Chen C, Clarke MA, Cook LS, Costas L, Dal Maso L, Freudenheim JL, Frias-Gomez J, Friedenreich CM, Garcia-Closas M, ... ... Yu H, et al. Risk prediction models for endometrial cancer: development and validation in an international consortium. Journal of the National Cancer Institute. PMID 36688725 DOI: 10.1093/jnci/djad014 |
0.314 |
|
| 2022 |
Brasky TM, Hade EM, Cohn DE, Newton AM, Petruzella S, O'Connell K, Bertrand KA, Cook LS, De Vivo I, Du M, Freudenheim JL, Friedenreich CM, Goodman MT, Gorzelitz J, Ibiebele TI, ... ... Yu H, et al. Dietary omega-3 fatty acids and endometrial cancer risk in the Epidemiology of Endometrial Cancer Consortium: An individual-participant meta-analysis. Gynecologic Oncology. 169: 137-146. PMID 36934308 DOI: 10.1016/j.ygyno.2022.10.015 |
0.306 |
|
| 2022 |
Wang J, Katsaros D, Biglia N, Fu Y, Benedetto C, Loo L, Wang Z, Yu H. LncRNA Expression and Methylation in Breast Cancer and Its Biological and Clinical Implications. Cancers. 14. PMID 35681777 DOI: 10.3390/cancers14112788 |
0.404 |
|
| 2021 |
Dlamini Z, Hull R, Mbatha SZ, Alaouna M, Qiao YL, Yu H, Chatziioannou A. Prognostic Alternative Splicing Signatures in Esophageal Carcinoma. Cancer Management and Research. 13: 4509-4527. PMID 34113176 DOI: 10.2147/CMAR.S305464 |
0.315 |
|
| 2021 |
Sarink D, Franke AA, White KK, Wu AH, Cheng I, Quon B, Le Marchand L, Wilkens LR, Yu H, Merritt MA. BPA, Parabens, and Phthalates in Relation to Endometrial Cancer Risk: A Case-Control Study Nested in the Multiethnic Cohort. Environmental Health Perspectives. 129: 57702. PMID 33950701 DOI: 10.1289/EHP8998 |
0.318 |
|
| 2021 |
Jung SY, Papp JC, Sobel EM, Pellegrini M, Yu H, Zhang ZF. Pro-inflammatory cytokine polymorphisms and interactions with dietary alcohol and estrogen, risk factors for invasive breast cancer using a post genome-wide analysis for gene-gene and gene-lifestyle interaction. Scientific Reports. 11: 1058. PMID 33441805 DOI: 10.1038/s41598-020-80197-1 |
0.349 |
|
| 2020 |
Jung SY, Papp JC, Sobel EM, Pellegrini M, Yu H, Zhang ZF. Genetically Predicted C-Reactive Protein Associated With Postmenopausal Breast Cancer Risk: Interrelation With Estrogen and Cancer Molecular Subtypes Using Mendelian Randomization. Frontiers in Oncology. 10: 630994. PMID 33614510 DOI: 10.3389/fonc.2020.630994 |
0.339 |
|
| 2020 |
Jung SY, Scott PA, Papp JC, Sobel EM, Pellegrini M, Yu H, Han S, Zhang ZF. Genome-wide association analysis of pro-inflammatory cytokines and gene-lifestyle interaction for invasive breast cancer risk: the WHI dbGaP Study. Cancer Prevention Research (Philadelphia, Pa.). PMID 32928877 DOI: 10.1158/1940-6207.Capr-20-0256 |
0.32 |
|
| 2020 |
Kho PF, Amant F, Annibali D, Ashton K, Attia J, Auer PL, Beckmann MW, Black A, Brinton L, Buchanan DD, Chanock SJ, Chen C, Chen MM, Cheng THT, Cook LS, ... ... Yu H, et al. Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer. International Journal of Cancer. PMID 32851660 DOI: 10.1002/Ijc.33206 |
0.334 |
|
| 2020 |
Lin Y, Nakatochi M, Hosono Y, Ito H, Kamatani Y, Inoko A, Sakamoto H, Kinoshita F, Kobayashi Y, Ishii H, Ozaka M, Sasaki T, Matsuyama M, Sasahira N, Morimoto M, ... ... Yu H, et al. Genome-wide association meta-analysis identifies GP2 gene risk variants for pancreatic cancer. Nature Communications. 11: 3175. PMID 32581250 DOI: 10.1038/S41467-020-16711-W |
0.333 |
|
| 2020 |
Kalachand RD, Stordal B, Madden S, Chandler B, Cunningham J, Goode EL, Ruscito I, Braicu EI, Sehouli J, Ignatov A, Yu H, Katsaros D, Mills GB, Lu KH, Carey MS, et al. BRCA1 promoter methylation and clinical outcomes in ovarian cancer: an individual patient data meta-analysis. Journal of the National Cancer Institute. PMID 32413141 DOI: 10.1093/jnci/djaa070 |
0.38 |
|
| 2020 |
Zhong J, Jermusyk A, Wu L, Hoskins JW, Collins I, Mocci E, Zhang M, Song L, Chung CC, Zhang T, Xiao W, Albanes D, Andreotti G, Arslan AA, Babic A, ... ... Yu H, et al. A Transcriptome-Wide Association Study (TWAS) Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer. Journal of the National Cancer Institute. PMID 31917448 DOI: 10.1093/Jnci/Djz246 |
0.311 |
|
| 2020 |
Jung SY, Scott P, Han S, Pellegrini M, Papp J, Sobel E, Yu H, Zhang Z. Abstract 4614: Genome-wide association analysis of pro-inflammatory cytokines and gene-lifestyle interaction for invasive breast cancer risk: The WHI Database for Genotypes and Phenotypes Study Epidemiology. DOI: 10.1158/1538-7445.Am2020-4614 |
0.403 |
|
| 2019 |
Wang Z, Katsaros D, Biglia N, Shen Y, Fu Y, Tiirikainen M, Yu H. Low expression of WWC1, a tumor suppressor gene, is associated with aggressive breast cancer and poor survival outcome. Febs Open Bio. PMID 31102318 DOI: 10.1002/2211-5463.12659 |
0.409 |
|
| 2019 |
Chen F, Childs EJ, Mocci E, Bracci PM, Gallinger S, Li D, Neale RE, Olson SH, Scelo G, Bamlet WR, Blackford AL, Borges M, Brennan P, Chaffee KG, Duggal P, ... ... Yu H, et al. Analysis of heritability and genetic architecture of Pancreatic Cancer: A PanC4 Study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31015203 DOI: 10.1158/1055-9965.Epi-18-1235 |
0.322 |
|
| 2019 |
Jung SY, Papp JC, Sobel EM, Yu H, Zhang ZF. Breast cancer risk and insulin resistance: post genome-wide gene-environment interaction study using a random survival forest. Cancer Research. PMID 30936085 DOI: 10.1158/0008-5472.Can-18-3688 |
0.376 |
|
| 2019 |
Huang GS, Merritt MA, Hutson A, Strickler HD, Einstein M, Brouwer-Visser J, Ramirez NC, Lankes HA, El-Bahrawy M, Xue X, Yu H, Mannel RS, O'Malley DM, Mutch DG, Disilvestro P, et al. Sex hormone, insulin, and insulin-like growth factor signaling in recurrence of high stage endometrial cancer: Results from the NRG Oncology/Gynecologic Oncology Group 210 trial. Journal of Clinical Oncology. 37: 5509-5509. DOI: 10.1200/Jco.2019.37.15_Suppl.5509 |
0.354 |
|
| 2019 |
Obata Y, Katsaros D, Biglia N, Shen Y, Fu Y, Wang Z, Yu H. Abstract 3545: High expression of miR-30a is associated with favorable breast cancer survival Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-3545 |
0.371 |
|
| 2019 |
Jung SY, Yu H, Pellegrini M, Papp J, Sobel E, Zhang Z. Abstract 1596: Genome-wide gene-environmental interaction and random survival forest analyses: Insulin resistance and breast cancer risk Epidemiology. DOI: 10.1158/1538-7445.Sabcs18-1596 |
0.422 |
|
| 2018 |
Jung SY, Mancuso N, Yu H, Papp J, Sobel EM, Zhang ZF. Genome-wide meta-analysis of gene-environmental interaction for insulin-resistance phenotypes and breast cancer risk in postmenopausal women. Cancer Prevention Research (Philadelphia, Pa.). PMID 30327367 DOI: 10.1158/1940-6207.Capr-18-0180 |
0.344 |
|
| 2018 |
O'Mara TA, Glubb DM, Amant F, Annibali D, Ashton K, Attia J, Auer PL, Beckmann MW, Black A, Bolla MK, Brauch H, Brenner H, Brinton L, Buchanan DD, Burwinkel B, ... ... Yu H, et al. Identification of nine new susceptibility loci for endometrial cancer. Nature Communications. 9: 3166. PMID 30093612 DOI: 10.1038/S41467-018-05427-7 |
0.381 |
|
| 2018 |
Wang Z, Katsaros D, Biglia N, Shen Y, Fu Y, Loo LWM, Jia W, Obata Y, Yu H. High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival. Breast Cancer Research and Treatment. PMID 29845475 DOI: 10.1007/s10549-018-4839-2 |
0.341 |
|
| 2018 |
Mao C, Wang X, Liu Y, Wang M, Yan B, Jiang Y, Shi Y, Shen Y, Liu X, Liai W, Yang R, Xiao D, Cheng Y, Liu S, Zhou H, ... ... Yu H, et al. A G3BP1-interacting lncRNA promotes ferroptosis and apoptosis in cancer via nuclear sequestration of p53. Cancer Research. PMID 29588351 DOI: 10.1158/0008-5472.Can-17-3454 |
0.338 |
|
| 2018 |
Klein AP, Wolpin BM, Risch HA, Stolzenberg-Solomon RZ, Mocci E, Zhang M, Canzian F, Childs EJ, Hoskins JW, Jermusyk A, Zhong J, Chen F, Albanes D, Andreotti G, Arslan AA, ... ... Yu H, et al. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Nature Communications. 9: 556. PMID 29422604 DOI: 10.1038/S41467-018-02942-5 |
0.319 |
|
| 2018 |
Wang Y, Ma R, Lin H, Yu X, Yu H, Qian B. Abstract 240: SNP-mediated repression of DCBLD1 by YY1 may explain a GWAS finding on lung cancer Epidemiology. DOI: 10.1158/1538-7445.Am2018-240 |
0.379 |
|
| 2017 |
Ma R, Feng N, Yu X, Lin H, Zhang X, Shi O, Zhang H, Zhang S, Li L, Zheng M, Gao M, Yu H, Qian B. Promoter methylation of Wnt/β-Catenin signal inhibitor TMEM88 is associated with unfavorable prognosis of non-small cell lung cancer. Cancer Biology & Medicine. 14: 377-386. PMID 29372104 DOI: 10.20892/j.issn.2095-3941.2017.0061 |
0.314 |
|
| 2017 |
Jordan SJ, Na R, Johnatty SE, Wise LA, Adami HO, Brinton LA, Chen C, Cook LS, Dal Maso L, De Vivo I, Freudenheim JL, Friedenreich CM, La Vecchia C, McCann SE, Moysich KB, ... ... Yu H, et al. Breastfeeding and Endometrial Cancer Risk: An Analysis From the Epidemiology of Endometrial Cancer Consortium. Obstetrics and Gynecology. PMID 28486362 DOI: 10.1097/Aog.0000000000002057 |
0.4 |
|
| 2016 |
Risch HA, Lu L, Streicher SA, Wang J, Zhang W, Ni Q, Kidd MS, Yu H, Gao YT. Aspirin Use and Reduced Risk of Pancreatic Cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27999143 DOI: 10.1158/1055-9965.Epi-16-0508 |
0.325 |
|
| 2016 |
Oikonomopoulou K, Yu H, Wang Z, Vasiliou SK, Brinc D, Christofi G, Theodorou M, Pavlou P, Hadjisavvas A, Demetriou CA, Kyriacou K, Diamandis EP. Association between Echinococcus granulosus infection and cancer risk - a pilot study in Cyprus. Clinical Chemistry and Laboratory Medicine. PMID 27327131 DOI: 10.1515/Cclm-2016-0125 |
0.403 |
|
| 2016 |
Ching T, Peplowska K, Huang S, Zhu X, Shen Y, Molnar J, Yu H, Tiirikainen M, Fogelgren B, Fan R, Garmire LX. Pan-Cancer Analyses Reveal Long Intergenic Non-Coding RNAs Relevant to Tumor Diagnosis, Subtyping and Prognosis. Ebiomedicine. 7: 62-72. PMID 27322459 DOI: 10.1016/J.Ebiom.2016.03.023 |
0.378 |
|
| 2016 |
Lujan-Barroso L, Zhang W, Olson SH, Gao YT, Yu H, Baghurst PA, Bracci PM, Bueno-de-Mesquita B, Foretová L, Gallinger S, Holcatova I, Janout V, Ji BT, Kurtz RC, La Vecchia C, et al. Menstrual and Reproductive Factors, Hormone Use, and Risk of Pancreatic Cancer: Analysis From the International Pancreatic Cancer Case-Control Consortium (PanC4). Pancreas. PMID 27088489 DOI: 10.1097/Mpa.0000000000000635 |
0.344 |
|
| 2016 |
Chen MM, O'Mara TA, Thompson DJ, Painter JN, Attia J, Black A, Brinton L, Chanock S, Chen C, Cheng TH, Cook LS, Crous-Bou M, Doherty J, Friedenreich CM, ... ... Yu H, et al. GWAS meta-analysis of 16,852 women identifies new susceptibility locus for endometrial cancer. Human Molecular Genetics. PMID 27008869 DOI: 10.1093/Hmg/Ddw092 |
0.314 |
|
| 2015 |
Prescott J, Setiawan VW, Wentzensen N, Schumacher F, Yu H, Delahanty R, Bernstein L, Chanock SJ, Chen C, Cook LS, Friedenreich C, Garcia-Closas M, Haiman CA, Le Marchand L, Liang X, et al. Body Mass Index Genetic Risk Score and Endometrial Cancer Risk. Plos One. 10: e0143256. PMID 26606540 DOI: 10.1371/Journal.Pone.0143256 |
0.412 |
|
| 2015 |
Shen Y, Wang Z, Loo LW, Ni Y, Jia W, Fei P, Risch HA, Katsaros D, Yu H. LINC00472 expression is regulated by promoter methylation and associated with disease-free survival in patients with grade 2 breast cancer. Breast Cancer Research and Treatment. PMID 26564482 DOI: 10.1007/S10549-015-3632-8 |
0.387 |
|
| 2015 |
Wang Z, Risch H, Lu L, Irwin ML, Mayne S, Schwartz P, Rutherford T, De Vivo I, Yu H. Joint Effect of Genotypic and Phenotypic Features of Reproductive Factors on Endometrial Cancer Risk. Scientific Reports. 5: 15582. PMID 26498156 DOI: 10.1038/Srep15582 |
0.362 |
|
| 2015 |
Sampson JN, Wheeler WA, Yeager M, Panagiotou O, Wang Z, Berndt SI, Lan Q, Abnet CC, Amundadottir LT, Figueroa JD, Landi MT, Mirabello L, Savage SA, Taylor PR, Vivo ID, ... ... Yu H, et al. Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. Journal of the National Cancer Institute. 107. PMID 26464424 DOI: 10.1093/Jnci/Djv279 |
0.321 |
|
| 2015 |
Xie G, Zhou B, Zhao A, Qiu Y, Zhao X, Garmire L, Shvetsov YB, Yu H, Yen Y, Jia W. Lowered circulating aspartate is a metabolic feature of human breast cancer. Oncotarget. PMID 26452258 DOI: 10.18632/oncotarget.5409 |
0.356 |
|
| 2015 |
Wang Z, Katsaros D, Shen Y, Fu Y, Canuto EM, Benedetto C, Lu L, Chu WM, Risch HA, Yu H. Biological and Clinical Significance of MAD2L1 and BUB1, Genes Frequently Appearing in Expression Signatures for Breast Cancer Prognosis. Plos One. 10: e0136246. PMID 26287798 DOI: 10.1371/Journal.Pone.0136246 |
0.332 |
|
| 2015 |
Risch HA, Yu H, Lu L, Kidd MS. Risch et al. Respond to "Clinical Utility of Prediction Models for Rare Outcomes: The Example of Pancreatic Cancer". American Journal of Epidemiology. 182: 39-40. PMID 26049861 DOI: 10.1093/Aje/Kwv025 |
0.311 |
|
| 2015 |
Risch HA, Yu H, Lu L, Kidd MS. Detectable Symptomatology Preceding the Diagnosis of Pancreatic Cancer and Absolute Risk of Pancreatic Cancer Diagnosis. American Journal of Epidemiology. 182: 26-34. PMID 26049860 DOI: 10.1093/Aje/Kwv026 |
0.413 |
|
| 2015 |
Arem H, Yu K, Xiong X, Moy K, Freedman ND, Mayne ST, Albanes D, Amundadottir LT, Arslan AA, Austin M, Bamlet WR, Beane-Freeman L, Bracci P, Canzian F, Chanock SJ, ... ... Yu H, et al. Correction: Vitamin D Metabolic Pathway Genes and Pancreatic Cancer Risk. Plos One. 10: e0129983. PMID 26039095 DOI: 10.1371/Journal.Pone.0129983 |
0.39 |
|
| 2015 |
Su D, Katsaros D, Xu S, Xu H, Gao Y, Biglia N, Feng J, Ying L, Zhang P, Benedetto C, Yu H. ADP-ribosylation factor-like 4C (ARL4C), a novel ovarian cancer metastasis suppressor, identified by integrated genomics. American Journal of Translational Research. 7: 242-56. PMID 25901194 |
0.365 |
|
| 2015 |
Shen Y, Katsaros D, Loo LW, Hernandez BY, Chong C, Canuto EM, Biglia N, Lu L, Risch H, Chu WM, Yu H. Prognostic and predictive values of long non-coding RNA LINC00472 in breast cancer. Oncotarget. 6: 8579-92. PMID 25865225 DOI: 10.18632/Oncotarget.3287 |
0.313 |
|
| 2015 |
Lu L, Katsaros D, Risch HA, Canuto EM, Biglia N, Yu H. MicroRNA let-7a Modifies the Effect of Self-Renewal Gene HIWI on Patient Survival of Epithelial Ovarian Cancer. Molecular Carcinogenesis. PMID 25630839 DOI: 10.1002/Mc.22285 |
0.36 |
|
| 2015 |
Gunter MJ, Xie X, Xue X, Kabat GC, Rohan TE, Wassertheil-Smoller S, Ho GY, Wylie-Rosett J, Greco T, Yu H, Beasley J, Strickler HD. Breast cancer risk in metabolically healthy but overweight postmenopausal women. Cancer Research. 75: 270-4. PMID 25593034 DOI: 10.1158/0008-5472.CAN-14-2317 |
0.308 |
|
| 2015 |
Kong J, Xu F, Qu J, Wang Y, Gao M, Yu H, Qian B. Abstract 4601: Genetic polymorphisms in the vitamin D pathway in relation to lung cancer risk and survival Epidemiology. 75: 4601-4601. DOI: 10.1158/1538-7445.Am2015-4601 |
0.368 |
|
| 2015 |
Ching T, Peplowska K, Huang S, Zhu X, Shen Y, Molnar J, Yu H, Tiirikainen M, Fogelgren B, Fan R, Garmire LX. Pan-Cancer Analyses Reveal Long Intergenic Non-Coding RNAs Relevant to Tumor Diagnosis, Subtyping and Prognosis Ebiomedicine. DOI: 10.1016/j.ebiom.2016.03.023 |
0.378 |
|
| 2014 |
Streicher SA, Yu H, Lu L, Kidd MS, Risch HA. Case-control study of aspirin use and risk of pancreatic cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1254-63. PMID 24969230 DOI: 10.1158/1055-9965.Epi-13-1284 |
0.361 |
|
| 2014 |
Setiawan VW, Schumacher F, Prescott J, Haessler J, Malinowski J, Wentzensen N, Yang H, Chanock S, Brinton L, Hartge P, Lissowska J, Park SL, Cheng I, Bush WS, Crawford DC, ... ... Yu H, et al. Cross-cancer pleiotropic analysis of endometrial cancer: PAGE and E2C2 consortia. Carcinogenesis. 35: 2068-73. PMID 24832084 DOI: 10.1093/Carcin/Bgu107 |
0.413 |
|
| 2014 |
Chen MM, Crous-Bou M, Setiawan VW, Prescott J, Olson SH, Wentzensen N, Black A, Brinton L, Chen C, Chen C, Cook LS, Doherty J, Friedenreich CM, Hankinson SE, Hartge P, ... ... Yu H, et al. Exome-wide association study of endometrial cancer in a multiethnic population. Plos One. 9: e97045. PMID 24810602 DOI: 10.1371/Journal.Pone.0097045 |
0.301 |
|
| 2014 |
Lee LJ, Ratner E, Uduman M, Winter K, Boeke M, Greven KM, King S, Burke TW, Underhill K, Kim H, Boulware RJ, Yu H, Parkash V, Lu L, Gaffney D, et al. The KRAS-variant and miRNA expression in RTOG endometrial cancer clinical trials 9708 and 9905. Plos One. 9: e94167. PMID 24732316 DOI: 10.1371/Journal.Pone.0094167 |
0.403 |
|
| 2014 |
Xu HL, Cheng JR, Zhang W, Wang J, Yu H, Ni QX, Risch HA, Gao YT. Re-evaluation of ABO gene polymorphisms detected in a genomewide association study and risk of pancreatic ductal adenocarcinoma in a Chinese population Chinese Journal of Cancer. 33: 68-73. PMID 23816557 DOI: 10.5732/Cjc.013.10060 |
0.317 |
|
| 2014 |
Yang HP, Cook LS, Weiderpass E, Adami H, Anderson KE, Cai H, Cerhan JR, Clendenen T, Felix AS, Friedenreich C, Garcia-Closas M, Goodman MT, Liang X, Lissowska J, Lu L, ... ... Yu H, et al. Abstract 2167: Infertility and risk of incident endometrial carcinoma: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium Cancer Research. 74: 2167-2167. DOI: 10.1158/1538-7445.Am2014-2167 |
0.334 |
|
| 2013 |
Bosetti C, Lucenteforte E, Bracci PM, Negri E, Neale RE, Risch HA, Olson SH, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Baghurst PA, Zatonski W, ... ... Yu H, et al. Ulcer, gastric surgery and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 24: 2903-10. PMID 23970016 DOI: 10.1093/Annonc/Mdt336 |
0.441 |
|
| 2013 |
Lu L, Risch E, Deng Q, Biglia N, Picardo E, Katsaros D, Yu H. An insulin-like growth factor-II intronic variant affects local DNA conformation and ovarian cancer survival. Carcinogenesis. 34: 2024-30. PMID 23677070 DOI: 10.1093/Carcin/Bgt168 |
0.473 |
|
| 2013 |
Risch HA, Lu L, Wang J, Zhang W, Ni Q, Gao YT, Yu H. ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis. American Journal of Epidemiology. 177: 1326-37. PMID 23652164 DOI: 10.1093/Aje/Kws458 |
0.352 |
|
| 2013 |
Ying L, Su D, Zhu J, Ma S, Katsaros D, Yu H. Genotyping of stathmin and its association with clinical factors and survival in patients with ovarian cancer. Oncology Letters. 5: 1315-1320. PMID 23599786 DOI: 10.3892/ol.2013.1144 |
0.348 |
|
| 2013 |
Olsen CM, Nagle CM, Whiteman DC, Ness R, Pearce CL, Pike MC, Rossing MA, Terry KL, Wu AH, Risch HA, Yu H, Doherty JA, Chang-Claude J, et al. Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocrine-Related Cancer. 20: 251-62. PMID 23404857 DOI: 10.1530/Erc-12-0395 |
0.386 |
|
| 2013 |
Leenders M, Bhattacharjee S, Vineis P, Stevens V, Bueno-de-Mesquita HB, Shu XO, Amundadottir L, Gross M, Tobias GS, Wactawski-Wende J, Arslan AA, Duell EJ, Fuchs CS, Gallinger S, Hartge P, ... ... Yu H, et al. Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4. Cancer Causes & Control : Ccc. 24: 595-602. PMID 23334854 DOI: 10.1007/S10552-012-0138-0 |
0.371 |
|
| 2013 |
Delahanty RJ, Xiang YB, Spurdle A, Beeghly-Fadiel A, Long J, Thompson D, Tomlinson I, Yu H, Lambrechts D, Dörk T, Goodman MT, Zheng Y, Salvesen HB, Bao PP, Amant F, et al. Polymorphisms in inflammation pathway genes and endometrial cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 216-23. PMID 23221126 DOI: 10.1158/1055-9965.Epi-12-0903 |
0.326 |
|
| 2013 |
Jones SB, Thomas GA, Hesselsweet SD, Alvarez-Reeves M, Yu H, Irwin ML. Effect of exercise on markers of inflammation in breast cancer survivors: the Yale exercise and survivorship study. Cancer Prevention Research (Philadelphia, Pa.). 6: 109-18. PMID 23213072 DOI: 10.1158/1940-6207.Capr-12-0278 |
0.331 |
|
| 2013 |
Arem H, Neuhouser ML, Irwin ML, Cartmel B, Lu L, Risch H, Mayne ST, Yu H. Omega-3 and omega-6 fatty acid intakes and endometrial cancer risk in a population-based case-control study. European Journal of Nutrition. 52: 1251-60. PMID 22915050 DOI: 10.1007/S00394-012-0436-Z |
0.383 |
|
| 2013 |
Glasgow MA, Yu H, Rutherford TJ, Azodi M, Silasi DA, Santin AD, Schwartz PE. Neoadjuvant chemotherapy (NACT) is an effective way of managing elderly women with advanced stage ovarian cancer (FIGO Stage IIIC and IV). Journal of Surgical Oncology. 107: 195-200. PMID 22648987 DOI: 10.1002/Jso.23171 |
0.377 |
|
| 2012 |
Lu L, Zhu G, Zhang C, Deng Q, Katsaros D, Mayne ST, Risch HA, Mu L, Canuto EM, Gregori G, Benedetto C, Yu H. Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer. Breast Cancer Research and Treatment. 136: 875-83. PMID 23124417 DOI: 10.1007/S10549-012-2314-Z |
0.474 |
|
| 2012 |
Wang J, Zhang W, Sun L, Yu H, Ni QX, Risch HA, Gao YT. Green tea drinking and risk of pancreatic cancer: A large-scale, population-based case-control study in urban Shanghai Cancer Epidemiology. 36: e354-e358. PMID 22944495 DOI: 10.1016/J.Canep.2012.08.004 |
0.438 |
|
| 2012 |
Setiawan VW, Pike MC, Karageorgi S, Deming SL, Anderson K, Bernstein L, Brinton LA, Cai H, Cerhan JR, Cozen W, Chen C, Doherty J, Freudenheim JL, Goodman MT, Hankinson SE, ... ... Yu H, et al. Age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortium. American Journal of Epidemiology. 176: 269-78. PMID 22831825 DOI: 10.1093/Aje/Kws129 |
0.44 |
|
| 2012 |
Lu L, Katsaros D, Mayne ST, Risch HA, Benedetto C, Canuto EM, Yu H. Functional study of risk loci of stem cell-associated gene lin-28B and associations with disease survival outcomes in epithelial ovarian cancer. Carcinogenesis. 33: 2119-25. PMID 22822098 DOI: 10.1093/Carcin/Bgs243 |
0.324 |
|
| 2012 |
Duell EJ, Lucenteforte E, Olson SH, Bracci PM, Li D, Risch HA, Silverman DT, Ji BT, Gallinger S, Holly EA, Fontham EH, Maisonneuve P, Bueno-de-Mesquita HB, Ghadirian P, Kurtz RC, ... ... Yu H, et al. Pancreatitis and pancreatic cancer risk: A pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4) Annals of Oncology. 23: 2964-2970. PMID 22767586 DOI: 10.1093/Annonc/Mds140 |
0.431 |
|
| 2012 |
Jacobs KB, Yeager M, Zhou W, Wacholder S, Wang Z, Rodriguez-Santiago B, Hutchinson A, Deng X, Liu C, Horner MJ, Cullen M, Epstein CG, Burdett L, Dean MC, Chatterjee N, ... ... Yu H, et al. Detectable clonal mosaicism and its relationship to aging and cancer. Nature Genetics. 44: 651-8. PMID 22561519 DOI: 10.1038/Ng.2270 |
0.467 |
|
| 2012 |
Li D, Duell EJ, Yu K, Risch HA, Olson SH, Kooperberg C, Wolpin BM, Jiao L, Dong X, Wheeler B, Arslan AA, Bueno-de-Mesquita HB, Fuchs CS, Gallinger S, Gross M, ... ... Yu H, et al. Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer. Carcinogenesis. 33: 1384-90. PMID 22523087 DOI: 10.1093/Carcin/Bgs151 |
0.417 |
|
| 2012 |
Long J, Zheng W, Xiang YB, Lose F, Thompson D, Tomlinson I, Yu H, Wentzensen N, Lambrechts D, Dörk T, Dubrowinskaja N, Goodman MT, Salvesen HB, Fasching PA, Scott RJ, et al. Genome-wide association study identifies a possible susceptibility locus for endometrial cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 980-7. PMID 22426144 DOI: 10.1158/1055-9965.Epi-11-1160 |
0.332 |
|
| 2012 |
Su D, Xu H, Feng J, Gao Y, Gu L, Ying L, Katsaros D, Yu H, Xu S, Qi M. PDCD6 is an independent predictor of progression free survival in epithelial ovarian cancer. Journal of Translational Medicine. 10: 31. PMID 22369209 DOI: 10.1186/1479-5876-10-31 |
0.478 |
|
| 2012 |
Mu L, Tuck D, Katsaros D, Lu L, Schulz V, Perincheri S, Menato G, Scarampi L, Harris L, Yu H. Favorable outcome associated with an IGF-1 ligand signature in breast cancer. Breast Cancer Research and Treatment. 133: 321-31. PMID 22297468 DOI: 10.1007/S10549-012-1952-5 |
0.416 |
|
| 2012 |
Ratner ES, Keane FK, Lindner R, Tassi RA, Paranjape T, Glasgow M, Nallur S, Deng Y, Lu L, Steele L, Sand S, Muller RU, Bignotti E, Bellone S, Boeke M, ... ... Yu H, et al. A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer. Oncogene. 31: 4559-66. PMID 22139083 DOI: 10.1038/Onc.2011.539 |
0.451 |
|
| 2012 |
Zeng H, Irwin ML, Lu L, Risch H, Mayne S, Mu L, Deng Q, Scarampi L, Mitidieri M, Katsaros D, Yu H. Physical activity and breast cancer survival: an epigenetic link through reduced methylation of a tumor suppressor gene L3MBTL1. Breast Cancer Research and Treatment. 133: 127-35. PMID 21837478 DOI: 10.1007/S10549-011-1716-7 |
0.488 |
|
| 2012 |
Ji Y, Shen MC, Jin XL, Zhu MH, Wang H, Ni QX, Zhang W, Wang J, Sun L, Yu H, Risch H, Gao YT. Pathologic characteristics of pancreatic cancer in Shanghai urban area: Preliminary analysis of 350 cases Tumor. 32: 199-202. DOI: 10.3781/J.Issn.1000-7431.2012.03.009 |
0.399 |
|
| 2012 |
Delahanty RJ, Xiang Y, Spurdle A, Beeghly-Fadiel A, Long J, Thompson D, Tomlinson I, Yu H, Lambrechts D, Dörk T, Goodman MT, Salvesen HB, Lu W, Cai Q, Zheng W, et al. Abstract LB-331: Polymorphisms in inflammation pathway genes and endometrial cancer Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-331 |
0.484 |
|
| 2012 |
Lu L, Lee S, Mayne S, Irwin M, Cartmel B, Risch H, Yu H. Abstract 633: Synergistic interplay between long-term overweight and long menstrual years in endometrial cancer Cancer Research. 72: 633-633. DOI: 10.1158/1538-7445.Am2012-633 |
0.411 |
|
| 2012 |
Lu L, Katsaros D, Risch H, Yu H. Abstract 3655: Stem cell-associated gene Lin-28B genotype and phenotype in epithelial ovarian cancer and their associations with disease survival outcomes Cancer Research. 72: 3655-3655. DOI: 10.1158/1538-7445.Am2012-3655 |
0.467 |
|
| 2012 |
Setiawan VW, Yang HP, Pike MC, McCann S, Yu H, Xiang Y, Wolk A, Wentzensen N, Weiss NS, Webb PM, Brandt PAvd, Vijver Kvd, Thompson PJ, Strom BL, Spurdle AB, et al. Abstract 1029: The association of body mass index with risk of endometrial cancer subtypes: Pooled analysis in E2C2 Epidemiology. 72: 1029-1029. DOI: 10.1158/1538-7445.Am2012-1029 |
0.405 |
|
| 2012 |
Prescott J, Setiawan VW, Wentzensen N, Schumacher F, Yu H, Delahanty R, Chanock S, Chen C, Garcia-Closas M, Haiman CA, Hartge P, Horn-Ross P, Le Marchand L, Lissowska J, Lu L, et al. Abstract 14: Body mass index and type 2 diabetes genetic risk scores and endometrial cancer risk among women of European ancestry. Cancer Epidemiology Biomarkers & Prevention. 21: 14-14. DOI: 10.1158/1055-9965.Gwas-14 |
0.319 |
|
| 2011 |
Varughese J, Hui P, Lu L, Yu H, Schwartz PE. Clear cell cancer of the uterine corpus: the association of clinicopathologic parameters and treatment on disease progression. Journal of Oncology. 2011: 628084. PMID 22187554 DOI: 10.1155/2011/628084 |
0.431 |
|
| 2011 |
Cadmus Bertram LA, Chung G, Yu H, Salovey P, Irwin M. Feasibility of institutional registry-based recruitment for enrolling newly diagnosed breast cancer patients in an exercise trial. Journal of Physical Activity & Health. 8: 955-63. PMID 21885886 DOI: 10.1123/Jpah.8.7.955 |
0.388 |
|
| 2011 |
Lu L, Zhang C, Zhu G, Irwin M, Risch H, Menato G, Mitidieri M, Katsaros D, Yu H. Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome. Breast Cancer Research : Bcr. 13: R56. PMID 21645396 DOI: 10.1186/Bcr2893 |
0.426 |
|
| 2011 |
Lu L, Schwartz P, Scarampi L, Rutherford T, Canuto EM, Yu H, Katsaros D. MicroRNA let-7a: a potential marker for selection of paclitaxel in ovarian cancer management. Gynecologic Oncology. 122: 366-71. PMID 21571355 DOI: 10.1016/J.Ygyno.2011.04.033 |
0.356 |
|
| 2011 |
Qian B, Zheng H, Yu H, Chen K. Genotypes and phenotypes of IGF-I and IGFBP-3 in breast tumors among Chinese women. Breast Cancer Research and Treatment. 130: 217-26. PMID 21562710 DOI: 10.1007/S10549-011-1552-9 |
0.446 |
|
| 2011 |
Zeng H, Yu H, Lu L, Jain D, Kidd MS, Saif MW, Chanock SJ, Hartge P, Risch HA. Genetic effects and modifiers of radiotherapy and chemotherapy on survival in pancreatic cancer. Pancreas. 40: 657-63. PMID 21487324 DOI: 10.1097/Mpa.0B013E31821268D1 |
0.434 |
|
| 2011 |
Lu L, Risch H, Irwin ML, Mayne ST, Cartmel B, Schwartz P, Rutherford T, Yu H. Long-term overweight and weight gain in early adulthood in association with risk of endometrial cancer. International Journal of Cancer. Journal International Du Cancer. 129: 1237-43. PMID 21387312 DOI: 10.1002/Ijc.26046 |
0.358 |
|
| 2011 |
Ma X, Wang R, Galili N, Mayne ST, Wang SA, Yu H, Raza A. Cigarette smoking shortens the survival of patients with low-risk myelodysplastic syndromes. Cancer Causes & Control : Ccc. 22: 623-9. PMID 21287258 DOI: 10.1007/S10552-011-9735-6 |
0.328 |
|
| 2011 |
Bertuccio P, La Vecchia C, Silverman DT, Petersen GM, Bracci PM, Negri E, Li D, Risch HA, Olson SH, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, ... ... Yu H, et al. Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 22: 1420-6. PMID 21245160 DOI: 10.1093/Annonc/Mdq613 |
0.38 |
|
| 2011 |
Qian B, Zhang H, Zhang L, Zhou X, Yu H, Chen K. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. Lung Cancer (Amsterdam, Netherlands). 73: 138-46. PMID 21195504 DOI: 10.1016/J.Lungcan.2010.11.018 |
0.408 |
|
| 2011 |
Arem H, Irwin ML, Zhou Y, Lu L, Risch H, Yu H. Physical activity and endometrial cancer in a population-based case-control study. Cancer Causes & Control : Ccc. 22: 219-26. PMID 21110224 DOI: 10.1007/S10552-010-9689-0 |
0.369 |
|
| 2011 |
Qian B, Katsaros D, Lu L, Canuto EM, Benedetto C, Beeghly-Fadiel A, Yu H. IGF-II promoter specific methylation and expression in epithelial ovarian cancer and their associations with disease characteristics. Oncology Reports. 25: 203-13. PMID 21109978 DOI: 10.3892/Or_00001062 |
0.491 |
|
| 2011 |
Lu L, Katsaros D, Zhu Y, Hoffman A, Luca S, Marion CE, Mu L, Risch H, Yu H. Let-7a regulation of insulin-like growth factors in breast cancer. Breast Cancer Research and Treatment. 126: 687-94. PMID 20848182 DOI: 10.1007/S10549-010-1168-5 |
0.468 |
|
| 2011 |
Zeng H, Yu H, Lu L, Jain D, Kidd MS, Saif MW, Chanock SJ, Hartge P, Risch HA. Abstract 4668: Genetic effects and modifiers of radiotherapy and chemotherapy on survival in pancreatic cancer Cancer Research. 71: 4668-4668. DOI: 10.1158/1538-7445.Am2011-4668 |
0.474 |
|
| 2011 |
Lu L, Schwartz P, Scarampi L, Canuto EM, Rutherford T, Katsaros D, Yu H. Abstract 3156: MicroRNA let-7a is a possible new marker for predicting the effect of paclitaxel in epithelial ovarian cancer Cancer Research. 71: 3156-3156. DOI: 10.1158/1538-7445.Am2011-3156 |
0.428 |
|
| 2011 |
Bertuccio P, La Vecchia C, Silverman DT, Petersen GM, Bracci PM, Negri E, Li D, Risch HA, Olson SH, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, ... ... Yu H, et al. Reply to are cohort data on smokeless tobacco use and pancreatic cancer confounded by alcohol use? Annals of Oncology. 22: 1931-1932. DOI: 10.1093/Annonc/Mdr305 |
0.325 |
|
| 2011 |
Ratner E, Keane F, Yu H, Zelterman D, Rutherford T, Santin A, Schwartz P, Slack F, Levine D, Weidhaas J. A 3′ UTR KRAS variant as a biomarker of poor outcome and chemotherapy resistance in ovarian cancer (Gynecologic Oncology (2011) 120, (S3)) Gynecologic Oncology. 122: 205. DOI: 10.1016/J.Ygyno.2011.03.028 |
0.411 |
|
| 2011 |
Ratner E, Keane F, Yu H, Zelterman D, Rutherford T, Santin A, Schwartz P, Slack F, Levine D, Weidhaas J. RETRACTED: A 3’ UTR KRAS variant as a biomarker of poor outcome and chemotherapy resistance in ovarian cancer Gynecologic Oncology. 120: S3. DOI: 10.1016/J.Ygyno.2010.12.010 |
0.39 |
|
| 2010 |
Ratner E, Lu L, Boeke M, Barnett R, Nallur S, Chin LJ, Pelletier C, Blitzblau R, Tassi R, Paranjape T, Hui P, Godwin AK, Yu H, Risch H, Rutherford T, et al. A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk. Cancer Research. 70: 6509-15. PMID 20647319 DOI: 10.1158/0008-5472.Can-10-0689 |
0.456 |
|
| 2010 |
Risch HA, Yu H, Lu L, Kidd MS. ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study. Journal of the National Cancer Institute. 102: 502-5. PMID 20181960 DOI: 10.1093/Jnci/Djq007 |
0.402 |
|
| 2010 |
Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon RZ, Jacobs KB, Arslan AA, Bueno-de-Mesquita HB, Gallinger S, Gross M, Helzlsouer K, Holly EA, Jacobs EJ, Klein AP, LaCroix A, ... ... Yu H, et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nature Genetics. 42: 224-8. PMID 20101243 DOI: 10.1038/Ng.522 |
0.345 |
|
| 2010 |
Fowke JH, Matthews CE, Yu H, Cai Q, Cohen S, Buchowski MS, Zheng W, Blot WJ. Racial differences in the association between body mass index and serum IGF1, IGF2, and IGFBP3. Endocrine-Related Cancer. 17: 51-60. PMID 19786462 DOI: 10.1677/Erc-09-0023 |
0.352 |
|
| 2010 |
Yi C, Mu L, de la Longrais IA, Sochirca O, Arisio R, Yu H, Hoffman AE, Zhu Y, Katsaro D. The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer. Breast Cancer Research and Treatment. 120: 663-9. PMID 19649706 DOI: 10.1007/S10549-009-0484-0 |
0.515 |
|
| 2010 |
Katz A, Yu H, Elsahwi K, Ratner E, Silasi D, Santin A, Azodi M, Rutherford T, Schwartz PE, Abu-Khalaf MM. Retrospective analysis of elderly patients (pts) with primary epithelial ovarian cancer (EOC) age 70 or older. Journal of Clinical Oncology. 28. DOI: 10.1200/Jco.2010.28.15_Suppl.E15518 |
0.326 |
|
| 2010 |
Arem H, Irwin ML, Zhou Y, Lu L, Risch H, Yu H. Abstract B70: Physical activity and BMI in a population-based case-control study of endometrial cancer risk Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-10-B70 |
0.453 |
|
| 2010 |
Lu L, Katsaros D, Qian B, Preti M, Menato G, Beeghly A, Yu H. Abstract 834: IGF-II promoter specific methylation patterns are associated with its expression and disease progression in epithelial ovarian cancer Cancer Research. 70: 834-834. DOI: 10.1158/1538-7445.Am10-834 |
0.78 |
|
| 2010 |
Fowke JH, Williams S, Yu H, Signorello L, Blot WJ. Abstract PR-1: Genetic African ancestry and race differences in blood insulin-like growth factor 1 (IGF-1), IGF-2, and IGF binding protein 3 (IGFBP-3) Cancer Epidemiology, Biomarkers & Prevention. 19. DOI: 10.1158/1055-9965.Disp-10-Pr-3 |
0.329 |
|
| 2009 |
Jones BA, Christensen AR, Wise JP, Yu H. Glutathione S-transferase polymorphisms and survival in African-American and white colorectal cancer patients. Cancer Epidemiology. 33: 249-56. PMID 19748847 DOI: 10.1016/J.Canep.2009.08.004 |
0.405 |
|
| 2009 |
Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, LaCroix A, Zheng W, Albanes D, Bamlet W, Berg CD, ... ... Yu H, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nature Genetics. 41: 986-90. PMID 19648918 DOI: 10.1038/Ng.429 |
0.452 |
|
| 2009 |
Irwin ML, Alvarez-Reeves M, Cadmus L, Mierzejewski E, Mayne ST, Yu H, Chung GG, Jones B, Knobf MT, DiPietro L. Exercise improves body fat, lean mass, and bone mass in breast cancer survivors. Obesity (Silver Spring, Md.). 17: 1534-41. PMID 19629060 DOI: 10.1038/Oby.2009.18 |
0.316 |
|
| 2009 |
Lu L, Katsaros D, Shaverdashvili K, Qian B, Wu Y, de la Longrais IA, Preti M, Menato G, Yu H. Pluripotent factor lin-28 and its homologue lin-28b in epithelial ovarian cancer and their associations with disease outcomes and expression of let-7a and IGF-II. European Journal of Cancer (Oxford, England : 1990). 45: 2212-8. PMID 19477633 DOI: 10.1016/J.Ejca.2009.05.003 |
0.406 |
|
| 2009 |
Su D, Smith SM, Preti M, Schwartz P, Rutherford TJ, Menato G, Danese S, Ma S, Yu H, Katsaros D. Stathmin and tubulin expression and survival of ovarian cancer patients receiving platinum treatment with and without paclitaxel. Cancer. 115: 2453-63. PMID 19322891 DOI: 10.1002/Cncr.24282 |
0.401 |
|
| 2009 |
Cadmus LA, Salovey P, Yu H, Chung G, Kasl S, Irwin ML. Exercise and quality of life during and after treatment for breast cancer: results of two randomized controlled trials. Psycho-Oncology. 18: 343-52. PMID 19242918 DOI: 10.1002/Pon.1525 |
0.316 |
|
| 2009 |
Irwin ML, Varma K, Alvarez-Reeves M, Cadmus L, Wiley A, Chung GG, Dipietro L, Mayne ST, Yu H. Randomized controlled trial of aerobic exercise on insulin and insulin-like growth factors in breast cancer survivors: the Yale Exercise and Survivorship study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 306-13. PMID 19124513 DOI: 10.1158/1055-9965.Epi-08-0531 |
0.391 |
|
| 2009 |
Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Li J, Ho GY, Xue X, Anderson GL, Kaplan RC, Harris TG, Howard BV, Wylie-Rosett J, Burk RD, et al. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. Journal of the National Cancer Institute. 101: 48-60. PMID 19116382 DOI: 10.1093/Jnci/Djn415 |
0.457 |
|
| 2009 |
Swede H, Rohan TE, Yu H, Anderson JC, Stevens RG, Brokaw J, Levine J, Brenner BM, Malchoff CD, Duffy VB, Pleau DC, Rosenberg DW. Number of aberrant crypt foci associated with adiposity and IGF1 bioavailability. Cancer Causes & Control : Ccc. 20: 653-61. PMID 19067190 DOI: 10.1007/S10552-008-9278-7 |
0.427 |
|
| 2009 |
Moore SC, Leitzmann MF, Albanes D, Weinstein SJ, Snyder K, Virtamo J, Ahn J, Mayne ST, Yu H, Peters U, Gunter MJ. Adipokine genes and prostate cancer risk. International Journal of Cancer. Journal International Du Cancer. 124: 869-76. PMID 19035456 DOI: 10.1002/Ijc.24043 |
0.396 |
|
| 2009 |
Qian B, Katsaros D, Lu L, Preti M, Durando A, Arisio R, Mu L, Yu H. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1. Breast Cancer Research and Treatment. 117: 131-40. PMID 18932017 DOI: 10.1007/S10549-008-0219-7 |
0.321 |
|
| 2009 |
Mu L, Katsaros D, Wiley A, Lu L, de la Longrais IA, Smith S, Khubchandani S, Sochirca O, Arisio R, Yu H. Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics. Breast Cancer Research and Treatment. 115: 151-62. PMID 18481170 DOI: 10.1007/S10549-008-0046-X |
0.417 |
|
| 2009 |
Cadmus L, Yu H, Wiley A, Chung G, Irwin M. Effect Of Physical Activity On Weight And Body Composition In Breast Cancer Survivors: 1365 Medicine and Science in Sports and Exercise. 41: 10-11. DOI: 10.1249/01.Mss.0000354254.67034.14 |
0.361 |
|
| 2008 |
Mu L, Katsaros D, Lu L, Preti M, Durando A, Arisio R, Yu H. TGF-β1 genotype and phenotype in breast cancer and their associations with IGFs and patient survival British Journal of Cancer. 99: 1357-1363. PMID 18827819 DOI: 10.1038/Sj.Bjc.6604689 |
0.347 |
|
| 2008 |
Irwin ML, Cadmus L, Alvarez-Reeves M, O'Neil M, Mierzejewski E, Latka R, Yu H, Dipietro L, Jones B, Knobf MT, Chung GG, Mayne ST. Recruiting and retaining breast cancer survivors into a randomized controlled exercise trial: the Yale Exercise and Survivorship Study. Cancer. 112: 2593-606. PMID 18428192 DOI: 10.1002/Cncr.23446 |
0.37 |
|
| 2008 |
Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Manson JE, Li J, Harris TG, Rohan TE, Xue X, Ho GYF, Einstein MH, Kaplan RC, Burk RD, Wylie-Rosett J, Pollak MN, et al. A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer Cancer Epidemiology Biomarkers and Prevention. 17: 921-929. PMID 18398032 DOI: 10.1158/1055-9965.Epi-07-2686 |
0.432 |
|
| 2008 |
Lu L, Katsaros D, Wiley A, de la Longrais IA, Puopolo M, Yu H. Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression. Cancer Investigation. 26: 185-92. PMID 18259951 DOI: 10.1080/07357900701638343 |
0.543 |
|
| 2008 |
Visintin I, Feng Z, Longton G, Ward DC, Alvero AB, Lai Y, Tenthorey J, Leiser A, Flores-Saaib R, Yu H, Azori M, Rutherford T, Schwartz PE, Mor G. Diagnostic markers for early detection of ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 1065-72. PMID 18258665 DOI: 10.1158/1078-0432.Ccr-07-1569 |
0.456 |
|
| 2008 |
Harris TG, Burk RD, Yu H, Minkoff H, Massad LS, Watts DH, Zhong Y, Gange S, Kaplan RC, Anastos K, Levine AM, Moxley M, Xue X, Fazzari M, Palefsky JM, et al. Insulin-like growth factor axis and oncogenic human papillomavirus natural history. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 245-8. PMID 18199731 DOI: 10.1158/1055-9965.Epi-07-0686 |
0.329 |
|
| 2008 |
Strickler HD, Fazzari M, Kovacs A, Isasi C, Napolitano LA, Minkoff H, Gange S, Young M, Sharp GB, Kaplan RC, Cohen M, Gunter MJ, Harris TG, Yu H, Schoenbaum E, et al. Associations of insulin-like growth factor (IGF)-I and IGF-binding protein-3 with HIV disease progression in women. The Journal of Infectious Diseases. 197: 319-27. PMID 18177247 DOI: 10.1086/524848 |
0.3 |
|
| 2008 |
Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Howard BV, Wylie-Rosett J, Anderson GL, Ho GY, Kaplan RC, Li J, Xue X, Harris TG, Burk RD, et al. Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer Research. 68: 329-37. PMID 18172327 DOI: 10.1158/0008-5472.Can-07-2946 |
0.467 |
|
| 2008 |
Visintin I, Feng Z, Longton G, Ward DC, Alvero AB, Lai Y, Tenthorey J, Leiser A, Flores-Saaib R, Yu H, Azori M, Rutherford T, Schwartz PE, Mor G. Diagnostic markers for early detection of ovarian cancer (Clinical Cancer Research (2008) 14, (1065-1072)) Clinical Cancer Research. 14: 7158. DOI: 10.1158/1078-0432.Ccr-14-21-Cor |
0.452 |
|
| 2008 |
Mor G, Schwartz PE, Yu H. Reply to the letters to the editor from Greene et al Clinical Cancer Research. 14: 7577-7579. DOI: 10.1158/1078-0432.Ccr-08-2621 |
0.321 |
|
| 2007 |
Brokaw J, Katsaros D, Wiley A, Lu L, Su D, Sochirca O, de la Longrais IA, Mayne S, Risch H, Yu H. IGF-I in epithelial ovarian cancer and its role in disease progression. Growth Factors (Chur, Switzerland). 25: 346-54. PMID 18236213 DOI: 10.1080/08977190701838402 |
0.495 |
|
| 2007 |
Smith S, Su D, Rigault de la Longrais IA, Schwartz P, Puopolo M, Rutherford TJ, Mor G, Yu H, Katsaros D. ERCC1 genotype and phenotype in epithelial ovarian cancer identify patients likely to benefit from paclitaxel treatment in addition to platinum-based therapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 5172-9. PMID 18024864 DOI: 10.1200/Jco.2007.11.8547 |
0.394 |
|
| 2007 |
Lu L, Katsaros D, de la Longrais IA, Sochirca O, Yu H. Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis. Cancer Research. 67: 10117-22. PMID 17974952 DOI: 10.1158/0008-5472.Can-07-2544 |
0.434 |
|
| 2007 |
Lu L, Katsaros D, Wiley A, Rigault de la Longrais IA, Puopolo M, Yu H. Expression of MDR1 in epithelial ovarian cancer and its association with disease progression. Oncology Research. 16: 395-403. PMID 17913048 DOI: 10.3727/000000006783980892 |
0.49 |
|
| 2007 |
Fair AM, Dai Q, Shu XO, Matthews CE, Yu H, Jin F, Gao YT, Zheng W. Energy balance, insulin resistance biomarkers, and breast cancer risk. Cancer Detection and Prevention. 31: 214-9. PMID 17646056 DOI: 10.1016/J.Cdp.2007.04.003 |
0.446 |
|
| 2007 |
Beeghly AC, Katsaros D, Wiley AL, Rigault de la Longrais IA, Prescott AT, Chen H, Puopolo M, Rutherford TJ, Yu H. IGF-II promoter methylation and ovarian cancer prognosis. Journal of Cancer Research and Clinical Oncology. 133: 713-23. PMID 17569086 DOI: 10.1007/S00432-007-0211-3 |
0.77 |
|
| 2007 |
Moore SC, Leitzmann MF, Weinstein SJ, Snyder K, Albanes D, Virtamo J, Graubard BI, Mayne ST, Yu H, Peters U, Gunter MJ. Insulin resistance-related gene polymorphisms and risk of prostate cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1315-7. PMID 17548707 DOI: 10.1158/1055-9965.Epi-07-0191 |
0.34 |
|
| 2007 |
Hou JY, Kelly MG, Yu H, McAlpine JN, Azodi M, Rutherford TJ, Schwartz PE. Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease Gynecologic Oncology. 105: 211-217. PMID 17239941 DOI: 10.1016/J.Ygyno.2006.11.025 |
0.368 |
|
| 2007 |
Su D, Ma S, Liu P, Jiang Z, Lv W, Zhang Y, Deng Q, Smith S, Yu H. Genetic polymorphisms and treatment response in advanced non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 56: 281-8. PMID 17222938 DOI: 10.1016/J.Lungcan.2006.12.002 |
0.388 |
|
| 2007 |
Qian B, Su D, Yu H. Clinical oncology—A new era Chinese Journal of Clinical Oncology. 4: 6-8. DOI: 10.1007/S11805-007-0006-Y |
0.354 |
|
| 2006 |
Ma X, Yu H. Global burden of cancer. The Yale Journal of Biology and Medicine. 79: 85-94. PMID 17940618 |
0.353 |
|
| 2006 |
Wolfort R, de Benedetti A, Nuthalapaty S, Yu H, Chu QD, Li BD. Up-regulation of TLK1B by eIF4E overexpression predicts cancer recurrence in irradiated patients with breast cancer. Surgery. 140: 161-9. PMID 16904965 DOI: 10.1016/J.Surg.2006.05.001 |
0.437 |
|
| 2006 |
Lu L, Katsaros D, Wiley A, Rigault de la Longrais IA, Puopolo M, Schwartz P, Yu H. Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer. Gynecologic Oncology. 103: 990-5. PMID 16859738 DOI: 10.1016/J.Ygyno.2006.06.006 |
0.457 |
|
| 2006 |
Wiley A, Katsaros D, Chen H, Rigault de la Longrais IA, Beeghly A, Puopolo M, Singal R, Zhang Y, Amoako A, Zelterman D, Yu H. Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential. Cancer. 107: 299-308. PMID 16773633 DOI: 10.1002/Cncr.21992 |
0.777 |
|
| 2006 |
Byrnes K, White S, Chu Q, Meschonat C, Yu H, Johnson LW, Debenedetti A, Abreo F, Turnage RH, McDonald JC, Li BD. High eIF4E, VEGF, and microvessel density in stage I to III breast cancer. Annals of Surgery. 243: 684-90; discussion 6. PMID 16633004 DOI: 10.1097/01.Sla.0000216770.23642.D8 |
0.414 |
|
| 2006 |
Harris TG, Strickler HD, Yu H, Pollak MN, Monrad ES, Travin MI, Xue X, Rohan TE, Kaplan RC. Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3). Growth Hormone & Igf Research : Official Journal of the Growth Hormone Research Society and the International Igf Research Society. 16: 86-92. PMID 16530441 DOI: 10.1016/J.Ghir.2006.01.002 |
0.343 |
|
| 2006 |
Lu L, Katsaros D, Wiley A, Rigault de la Longrais IA, Risch HA, Puopolo M, Yu H. The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 1208-14. PMID 16489075 DOI: 10.1158/1078-0432.Ccr-05-1801 |
0.454 |
|
| 2006 |
Wiley A, Katsaros D, Fracchioli S, Yu H. Methylation of the insulin-like growth factor binding protein-3 gene and prognosis of epithelial ovarian cancer. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 16: 210-8. PMID 16445635 DOI: 10.1111/J.1525-1438.2006.00299.X |
0.523 |
|
| 2006 |
Beeghly A, Katsaros D, Chen H, Fracchioli S, Zhang Y, Massobrio M, Risch H, Jones B, Yu H. Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival Gynecologic Oncology. 100: 330-337. PMID 16199080 DOI: 10.1016/J.Ygyno.2005.08.035 |
0.776 |
|
| 2006 |
Wolfort RM, Chu QD, Turnage RH, Yu H, Nuthalapaty S, Benedetti AD, Li BD. Upregulation of TLK1B by eIF4E overexpression predicts cancer recurrence in irradiated breast cancer patients Journal of Surgical Research. 130: 218-219. DOI: 10.1016/J.Jss.2005.11.161 |
0.473 |
|
| 2005 |
McClusky DR, Chu Q, Yu H, Debenedetti A, Johnson LW, Meschonat C, Turnage R, McDonald JC, Abreo F, Li BD. A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-positive breast cancer. Annals of Surgery. 242: 584-90; discussion 5. PMID 16192819 DOI: 10.1097/01.Sla.0000184224.55949.90 |
0.481 |
|
| 2005 |
Wen W, Gao YT, Shu XO, Yu H, Cai Q, Smith JR, Zheng W. Insulin-like growth factor-I gene polymorphism and breast cancer risk in Chinese women. International Journal of Cancer. 113: 307-11. PMID 15386404 DOI: 10.1002/Ijc.20571 |
0.448 |
|
| 2005 |
Shi R, Yu H, McLarty JW, Glass J. IGF-I, testosterone and breast cancer risk International Journal of Cancer. 115: 498-498. DOI: 10.1002/Ijc.20833 |
0.453 |
|
| 2004 |
Tran N, Bharaj BS, Diamandis EP, Smith M, Li BD, Yu H. Short tandem repeat polymorphism and cancer risk: influence of laboratory analysis on epidemiologic findings. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 2133-40. PMID 15598771 |
0.308 |
|
| 2004 |
Sanderson M, Shu XO, Yu H, Dai Q, Malin AS, Gao YT, Zheng W. Insulin-like growth factor-I, soy protein intake, and breast cancer risk. Nutrition and Cancer. 50: 8-15. PMID 15572292 DOI: 10.1207/S15327914Nc5001_2 |
0.467 |
|
| 2004 |
Katsaros D, Cho W, Singal R, Fracchioli S, Longrais IARdl, Arisio R, Massobrio M, Smith M, Zheng W, Glass J, Yu H. Methylation of tumor suppressor gene p16 and prognosis of epithelial ovarian cancer Gynecologic Oncology. 94: 685-692. PMID 15350359 DOI: 10.1016/J.Ygyno.2004.06.018 |
0.485 |
|
| 2004 |
Ren Z, Cai Q, Shu XO, Cai H, Li C, Yu H, Gao YT, Zheng W. Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 1290-5. PMID 15298948 |
0.379 |
|
| 2004 |
Shi R, Yu H, McLarty J, Glass J. IGF-I and breast cancer: a meta-analysis. International Journal of Cancer. 111: 418-423. PMID 15221971 DOI: 10.1002/Ijc.20233 |
0.475 |
|
| 2004 |
Boyapati SM, Shu XO, Gao YT, Dai Q, Yu H, Cheng JR, Jin F, Zheng W. Correlation of blood sex steroid hormones with body size, body fat distribution, and other known risk factors for breast cancer in post-menopausal Chinese women. Cancer Causes & Control : Ccc. 15: 305-11. PMID 15090725 DOI: 10.1023/B:Caco.0000024256.48104.50 |
0.41 |
|
| 2004 |
Malin A, Dai Q, Yu H, Shu XO, Jin F, Gao YT, Zheng W. Evaluation of the Synergistic Effect of Insulin Resistance and Insulin-Like Growth Factors on the Risk of Breast Carcinoma Cancer. 100: 694-700. PMID 14770423 DOI: 10.1002/Cncr.20023 |
0.379 |
|
| 2004 |
Norton KS, McClusky D, Sen S, Yu H, Meschonat C, Debenedetti A, Li BD. TLK1B is elevated with eIF4E overexpression in breast cancer. The Journal of Surgical Research. 116: 98-103. PMID 14732354 DOI: 10.1016/J.Jss.2003.08.001 |
0.433 |
|
| 2004 |
Li L, Yu H, Schumacher F, Casey G, Witte JS. Relation of serum insulin-like growth factor-I (IGF-I) and IGF binding protein-3 to risk of prostate cancer (United States). Cancer Causes & Control : Ccc. 14: 721-6. PMID 14674736 DOI: 10.1023/A:1026383824791 |
0.361 |
|
| 2004 |
Zheng SL, Zheng W, Chang BL, Shu XO, Cai Q, Yu H, Dai Q, Xu J, Gao YT. Joint effect of estrogen receptor beta sequence variants and endogenous estrogen exposure on breast cancer risk in Chinese women. Cancer Research. 63: 7624-9. PMID 14633679 |
0.306 |
|
| 2004 |
Yu H, Shu XO, Li BD, Dai Q, Gao YT, Jin F, Zheng W. Joint effect of insulin-like growth factors and sex steroids on breast cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 12: 1067-73. PMID 14578144 |
0.361 |
|
| 2003 |
Dai Q, Franke AA, Yu H, Shu XO, Jin F, Hebert JR, Custer LJ, Gao YT, Zheng W. Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 12: 497-502. PMID 12814993 |
0.333 |
|
| 2003 |
Yu H, Shu XO, Shi R, Dai Q, Jin F, Gao YT, Li BD, Zheng W. Plasma sex steroid hormones and breast cancer risk in Chinese women. International Journal of Cancer. 105: 92-7. PMID 12672036 DOI: 10.1002/Ijc.11034 |
0.438 |
|
| 2003 |
Ho GYF, Melman A, Liu SM, Li M, Yu H, Negassa A, Burk RD, Hsing AW, Ghavamian R, Chua SC. Polymorphism of the insulin gene is associated with increased prostate cancer risk British Journal of Cancer. 88: 263-269. PMID 12610512 DOI: 10.1038/Sj.Bjc.6600747 |
0.457 |
|
| 2003 |
Matthews CE, Yu H, Jin F, Shu XO, Dai Q, Fowke JH, Gao YT, Zheng W. Physical Activity, Endogenous Hormones, And Breast Cancer Risk Medicine and Science in Sports and Exercise. 35. DOI: 10.1097/00005768-200305001-01997 |
0.414 |
|
| 2002 |
Yu H, Jin F, Shu XO, Li BD, Dai Q, Cheng JR, Berkel HJ, Zheng W. Insulin-like growth factors and breast cancer risk in Chinese women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 11: 705-12. PMID 12163322 |
0.384 |
|
| 2002 |
Li BD, Gruner JS, Abreo F, Johnson LW, Yu H, Nawas S, McDonald JC, DeBenedetti A. Prospective study of eukaryotic initiation factor 4E protein elevation and breast cancer outcome. Annals of Surgery. 235: 732-8; discussion 73. PMID 11981220 DOI: 10.1097/00000658-200205000-00016 |
0.432 |
|
| 2002 |
Yu H, Li BD, Smith M, Shi R, Berkel HJ, Kato I. Polymorphic CA repeats in the IGF-I gene and breast cancer. Breast Cancer Research and Treatment. 70: 117-22. PMID 11768601 DOI: 10.1023/A:1012947027213 |
0.348 |
|
| 2001 |
Li BD, Khosravi MJ, Berkel HJ, Diamandi A, Dayton MA, Smith M, Yu H. Free insulin-like growth factor-I and breast cancer risk. International Journal of Cancer. 91: 736-9. PMID 11267989 DOI: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1111>3.0.CO;2-# |
0.352 |
|
| 2000 |
Fracchioli S, Yu H, Massobrio M, Katsaros D. IGFBP-3 expression in epithelial ovarian cancer: Favorable association with clinico-pathological parameters and patient survival International Journal of Gynecology & Obstetrics. 70. DOI: 10.1016/S0020-7292(00)84530-0 |
0.469 |
|
| 1999 |
Yu H, Diamandis EP, Hoffman B. Elevated estradiol and testosterone levels and risk for breast cancer. Annals of Internal Medicine. 131: 715. PMID 10577342 DOI: 10.7326/0003-4819-131-9-199911020-00023 |
0.425 |
|
| Show low-probability matches. |